Infections in the Intensive Care Unit

  • Gregory J. Rossini
  • Wissam Chatila

Abstract

Acute bacterial meningitis (ABM) is a life-threatening and severe infection involving the membranes of the central nervous system (CNS). ABM often presents in fulminant fashion with multiple complications and a high fatality rate despite the availability of potent antimicrobial therapy. The annual incidence of ABM is approximately 3.0 cases per 100,000 population in the United States but varies greatly according to risk factors such as geography, race, and gender. Mortality rates also vary according to the same risk factors and depend on the type of invading pathogen, ranging from 6% for Haemophilus influenzae meningitis to 35% for nosocomial meningitis. Currently, two issues dominate the field of ABM: first, the change in epidemiology effected by the introduction of H. influenzae type b vaccine, and second, the emergence of multidrug-resistant Streptococcus pneumoniae as a new pathogen. Recognition of pathogens based on age and prompt initiation of antimicrobial therapy are the cornerstones of ABM management.

Keywords

Blood Culture Infective Endocarditis Nosocomial Infection Antimicrobial Therapy Nosocomial Pneumonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Quagliarello VJ, Scheld MW. Treatment of bacterial meningitis. N Engl Med J 336: 708–716.Google Scholar
  2. Tunkel AR, Scheid MW Bacterial infections of the central nervous system. In: Hall JB, Schmidt GA, Wood LD (eds.) Principles of Critical Care, 2nd Ed. New York: McGraw-Hill, 1998: 1275–1292.Google Scholar
  3. Cobbs GC, Carr MB. Endocarditis and other intravascular infections. In: Hall JB, Schmidt GA, Wood LD (eds.) Principles of Critical Care, 2nd Ed. New York: McGraw-Hill, 1998: 1232–1248.Google Scholar
  4. Light B. Approach to sepsis of unknown origin. In: Hall JB, Schmidt GA, Wood LD (eds.) Principles of Critical Care, 2nd Ed. New York: McGraw-Hill, 1998, 1159–1171.Google Scholar
  5. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340: 207–214.PubMedCrossRefGoogle Scholar
  6. Lode HM, Schaberg T, Rouby JJ. Nosocomial infection in the critically ill: The lung as a target organ. Anesthesiol 1996; 4: 757–759.Google Scholar
  7. Mandell LA, Campbell GD. Nosocomial pneumonia guidelines: an international perspective. Chest 1998; 113: 1885–193S.CrossRefGoogle Scholar
  8. Rello J, Rue M, Jubert P, et al. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997; 25: 1862–1867.PubMedCrossRefGoogle Scholar
  9. Chatila W, Manthous CA. Clostridium dicile causing sepsis and an acute abdomen in critically ill patients. Crit Care Med 1995; 23: 1146–1150.PubMedCrossRefGoogle Scholar
  10. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized controlled trial. Ann Intern Med 1997; 127: 257–266.PubMedGoogle Scholar
  11. Pearson ML. Guideline for prevention of intravascular device related infections: Part 1. Intravascular device-related infections: an overview. Am J Infect Control 1996; 24: 262–277.PubMedCrossRefGoogle Scholar
  12. Raad I. Intravascular catheter-related infections. Lancet 1998; 351: 893–898.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Gregory J. Rossini
  • Wissam Chatila

There are no affiliations available

Personalised recommendations